Stephen Feider, an officer at Beta Bionics, Inc., has filed a Form 144 to sell 744 shares of the company. This transaction is valued at approximately $12,649 and comes amid a backdrop of ongoing trading activity in the surgical and medical instruments industry.

The filing, dated November 9, 2026, indicates that Feider has been actively selling shares of Beta Bionics. Just days before this filing, on November 5, he sold 382 shares for gross proceeds of $6,508. This pattern of selling may reflect a broader trend in insider trading within the industry.

Background

Beta Bionics, Inc. is a company involved in the surgical and medical instruments sector, specifically categorized under the SIC code 3841. The company is incorporated in Delaware and has its business address at 11 Hughes, Irvine, CA 92618. As of the latest filing, Beta Bionics trades on the NASDAQ under the SEC file number 001-42491.

What the Filing Says

According to the filing, Feider's transaction involves selling common shares acquired through stock options. The filing states, "Stephen Feider has filed to sell 744 shares of Beta Bionics, Inc., valued at $12,649." The filing also notes that Feider has sold shares in the past three months, indicating a pattern of trading activity.

Impact

This filing may affect other investors and stakeholders in Beta Bionics, as insider selling can influence market perceptions. The surgical and medical instruments industry is closely watched, and such transactions by company officers often draw attention from analysts and investors alike.

What's Next

The filing does not say what happens next regarding Feider's ongoing trading activities or any potential future transactions.